#USA #New York #mental health #Prism #GrayMatters Health

GrayMatters Health Expands Advisory Team

GrayMatters Health (GMH), a trailblazer in the domain of digital brain biomarkers designed for mental healthcare, has made a significant announcement regarding the strengthening of its advisory team. The organization has onboarded five expert advisors whose rich backgrounds encompass policy, reimbursement, and clinical excellence. This strategic move aims to optimize the Prism platform, an evidence-based intervention dedicated to prompting patients in learning how to modulate brain activity, particularly in coping with PTSD and depression.

CEO Oded Kraft provided insight into this pivotal development, likening the role of these advisors to that of a prism - an entity that disperses light into a spectrum of colors. He emphasized the importance of bringing together varied perspectives to spearhead the transformation of psychiatry from traditional, subjective symptom evaluations towards a more objective, data-informed, and personalized healthcare model.

Among the newly appointed advisors is Patrick J. Kennedy, renowned for his advocacy in the mental health space and as the founder of The Kennedy Forum. Kennedy, a former US Congressman, stands at the forefront of initiatives that unify various stakeholders, including government leaders and philanthropists, to reform the health system in a manner that equates mental health to physical health in importance.

A Diverse and Experienced Advisor Team

The other experts joining GMH represent a wealth of knowledge and experience in mental health and neuromodulation.

1. Owen Scott Muir, MD, DFAACAP - Dr. Muir is not only a Child and Adult Psychiatrist but also a prolific author. He is a co-founder and the Chief Medical Officer at Radial, a network of Brain Medicine clinics focusing on advanced treatment methods. His contributions to the field include significant academic publications as well as accessible books such as The Frontier Psychiatrists.

2. Linda Carpenter, MD - As a Professor of Psychiatry at Brown University and Chief of the BRaIN program at Butler Hospital, Dr. Carpenter leads in both research and clinical practices. She has been pivotal in lobbying for insurance coverage for innovative treatments, thus expanding access to essential mental health resources.

3. Kenneth Pages, MD - A distinguished psychiatrist based in Tampa, Dr. Pages brings his expertise to GMH with a focus on clinical excellence in brain health. His practice combines advanced treatment modalities alongside traditional therapies to ensure comprehensive care for those battling depression and PTSD.

4. Ali A. Farooqui, MD - Dr. Farooqui, managing partner at Integrative Psychiatry, is a leading figure in psychiatric neuromodulation techniques. His national recognition underscores his adeptness in innovative treatments including ketamine, psychedelics, and other unique interventions.

Kirk Thelander, the Chief Commercial Officer at GrayMatters Health, remarked on the strategic selections of these advisors, highlighting their critical roles in policy, reimbursement, and clinical brilliance. The overarching goal remains clear: to usher in the next wave of commercial and clinical milestones for GMH.

About GrayMatters Health

Founded with the mission to innovate within the mental healthcare sector, GrayMatters Health leverages digital fMRI-informed biomarkers to enrich treatment solutions. One of their leading products, Prism™, empowers patients with self-neuromodulation capabilities. This works by helping individuals identify personal strategies for regulating brain activity linked to their mental disorders, enabling a better quality of life while managing conditions like PTSD and depression.

The company remains committed to collaborating with top mental health institutions in assessing and expanding the use of the Prism platform across various psychiatric conditions.

To learn more about their groundbreaking work, visit GrayMatters Health or follow their journey on LinkedIn.